Assessment of patient capability to self-adjust oral anticoagulant dose: amulticenter study on home use of a portable prothrombin time monitor (COAGUCHECK)
B. Cosmi et al., Assessment of patient capability to self-adjust oral anticoagulant dose: amulticenter study on home use of a portable prothrombin time monitor (COAGUCHECK), HAEMATOLOG, 85(8), 2000, pp. 826-831
Background and Objectives. Self-testing and self-monitoring with portable p
rothrombin time (PT) monitors has been shown to be feasible and safe. Howev
er the ability of patients an chronic oral anticoagulant therapy (OAT) to s
elf-adjust their dose without specific training has never been properly eva
luated. The aims of this study were to evaluate: 1) the ability of patients
on chronic OAT to self-adjust their dose without specific training; 2) the
integration of a portable PT monitor (Coagucheck, Roche Diagnostics, Germa
ny) for home use into routine patient care in anticoagulation
Design and Methods. A nested case-control study was conducted in four cente
rs of the Italian Federation of Anticoagulation Clinics (FCSA). Patients (n
=78) on stable OAT for at least 6 months (cases: 47 men, 31 women, age rang
e: 18-75 years) were enrolled on a volunteer basis after passing an Abbrevi
ated Mental Test and providing informed consent. After three instruction se
ssions on the use of Coaguchek, subjects performed the PT test at home, com
municated the INR results to the Center and suggested the dose adjustment a
nd date for next control as they thought appropriate. However, they were re
quested to follow the prescription made by the Center. Controls (78 subject
s) matched by age (+/- 5 years), sex and therapeutic range with the cases,
were selected from among those who attended the anticoagulation clinics and
managed by usual care.
Results. When compared with the dose prescribed by the Clinic, the dose sug
gested by warfarin and acenocoumarol users was equal to or within +/- 6% of
the mean weekly dose in 80% and 82% of suggestions, respectively. Time spe
nt in the therapeutic range during the study was the same (80%) for cases a
nd controls.
Interpretation and Conclusions. Selected patients on chronic anticoagulant
therapy can acquire a satisfactory ability for sell-adjustment of OAT dose
without specific training. (C)2000, Ferrata Storti Foundation.